18 June 2013
Keywords: Nitto Denko, Avecia Biotech, DNA and RNA-based therapeutics, Contract manufacturing, Nucleic acid drugs
Article | 07 February 2011
Japan’s leading diversified materials manufacturer, Nitto Denko Corp (TYO: 6988), last week announced that it has acquired privately-owned Avecia ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.